Showing results (31-40 of 49) with videos related to

Sort By:
Pageof 5
Molecular Pharmaceutics|July 3, 2024
Development and Validation of Novel Z-360-Based Macromolecules for the Active Targeting of CCK2-RElisa Vettorato, Marco Verona, Greta Bellio, et al.
Biochemical Pharmacology|February 23, 2013
Discovery of a new small-molecule inhibitor of p53-MDM2 interaction using a yeast-based approachMariana Leão, Clara Pereira, Alessandra Bisio, et al.
Cell Death & Disease|April 11, 2023
ETV7 reduces inflammatory responses in breast cancer cells by repressing the TNFR1/NF-κB axisErna Marija Meškytė, Laura Pezzè, Laura Bartolomei, et al.
Cell Death Discovery|December 5, 2025
Exploring p53 isoforms: unraveling heterogeneous p53 tumor suppressor functionality in uveal melanomaLaura Bartolomei, Yari Ciribilli, Samuele Brugnara, et al.
Cancers|August 14, 2025
Investigating the Influence of Conventional vs. Ultra-High Dose Rate Proton Irradiation Under Normoxic or Hypoxic Conditions on Multiple Developmental Endpoints in Zebrafish EmbryosAlessia Faggian, Gaia Pucci, Enrico Verroi, et al.
Cancers|September 10, 2021
DHX30 Coordinates Cytoplasmic Translation and Mitochondrial Function Contributing to Cancer Cell SurvivalBartolomeo Bosco, Annalisa Rossi, Dario Rizzotto, et al.
Nucleic Acids Research|July 30, 2013
Transactivation specificity is conserved among p53 family proteins and depends on a response element sequence codeYari Ciribilli, Paola Monti, Alessandra Bisio, et al.
Neoplasia (New York, N.Y.)|May 6, 2023
Mitochondrial rewiring drives metabolic adaptation to NAD(H) shortage in triple negative breast cancer cellsAgata Sofia Assuncao Carreira, Silvia Ravera, Chiara Zucal, et al.
European Journal of Pharmaceutical Sciences : Official Journal of the European Federation for Pharmaceutical Sciences|October 15, 2014
Oxazoloisoindolinones with in vitro antitumor activity selectively activate a p53-pathway through potential inhibition of the p53-MDM2 interactionJoana Soares, Nuno A L Pereira, Ângelo Monteiro, et al.
Oncotarget|January 7, 2016
Reactivation of wild-type and mutant p53 by tryptophanolderived oxazoloisoindolinone SLMP53-1, a novel anticancer small-moleculeJoana Soares, Liliana Raimundo, Nuno A L Pereira, et al.
Pageof 5